Desmoid Fibromatosis: Clinical Trials

9 trials for Desmoid Fibromatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 active not recruiting, 2 completed, 1 not yet recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Completed 1
Not applicable1Not yet recruiting 1
Phase 31Completed 1

Follow Desmoid Fibromatosis: new trials by email Literature Review of Desmoid Fibromatosis trials Research Report on Desmoid Fibromatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Desmoid Fibromatosis With Arterial Embolization
embolization therapy - Desmoid Fibromatosis
RecruitingIstituto Ortopedico Rizzoli202025-07-012025-09-12
Electrochemotherapy for Desmoid Tumors
Electrochemotherapy with bleomycin - Desmoid Fibromatosis
WithdrawnIstituto Ortopedico Rizzoli2024-10-172026-05-14
A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors
radiofrequency ablation - Desmoid Tumor, Desmoid Fibromatosis
Not applicableNot yet recruitingBlokhin's Russian Cancer Research Center272024-04-012024-04-10
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Biospecimen Collection, Computed Tomography, Echocardiography Test - Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis
Phase 2Active not recruitingChildren's Oncology Group312020-10-072026-10-01
Observing People With Desmoid-Type Fibromatosis
Cross-sectional imaging - Desmoid Fibromatosis
RecruitingMemorial Sloan Kettering Cancer Center1002020-02-192026-05-15
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Drug Eluting Bead Embolization (DEB) for Desmoid Fibromatosis - Desmoid, Desmoid Fibromatosis of Skin
Phase 2CompletedRabin Medical Center82018-10-112022-03-25
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)7982017-01-302026-06-17
Project: Every Child for Younger Patients With Cancer
Cytology Specimen Collection Procedure, Medical Chart Review - Adrenal Gland Pheochromocytoma, Carcinoma In Situ
RecruitingChildren's Oncology Group750002015-11-032026-08-25
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment - Desmoid Fibromatosis
Phase 3CompletedNational Cancer Institute (NCI)872014-03-212026-06-24

Narrower conditions

Desmoid Tumors (9)  ·  Fibroma (2)  ·  Pheochromocytoma (2)  ·  Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adrenocortical Carcinoma (1)  ·  Bile Duct Neoplasms (1)  ·  Carcinoma in Situ (1)  ·  Carcinoma, Acinar Cell (1)  ·  Carcinoma, Adenoid Cystic (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Endometrioid (1)  ·  Carcinoma, Giant Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)

Broader conditions

Neoplasms by Histologic Type (9)  ·  Neoplasms, Connective Tissue (9)  ·  Neoplasms, Connective and Soft Tissue (9)  ·  Neoplasms, Fibrous Tissue (9)  ·  Neoplasms (8)  ·  Fibroma (7)  ·  Carcinoma (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Nervous System Diseases (2)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  Bleomycin (1)  ·  CTLA-4 Antigen (1)  ·  Electrochemotherapy (1)  ·  Embolization, Therapeutic (1)  ·  Ipilimumab (1)  ·  Nivolumab (1)  ·  Phantoms, Imaging (1)  ·  Radiofrequency Ablation (1)  ·  Sorafenib (1)  ·  X-Rays (1)  ·  nirogacestat (1)

Sponsors

Children's Oncology Group (2)  ·  Istituto Ortopedico Rizzoli (2)  ·  National Cancer Institute (NCI) (2)  ·  Blokhin's Russian Cancer Research Center (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Rabin Medical Center (1)

Countries

United States (5)  ·  Canada (3)  ·  Australia (2)  ·  Italy (2)  ·  New Zealand (2)  ·  Puerto Rico (2)  ·  Guam (1)  ·  Israel (1)  ·  Russia (1)  ·  Saudi Arabia (1)

Top investigators

Aimee M Crago, MD, PhD (1)  ·  Douglas S Hawkins (1)  ·  Fariba Navid (1)  ·  Giancarlo Facchini, Medicine and Surgery (1)  ·  Mrinal M Gounder (1)  ·  Sandip P Patel (1)

Results publications

PMID 30575484, PMID 31969335, PMID 33258687, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34420143, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790

NIH funding

U10CA031946 (1), U10CA098543 (1), U10CA180821 (1), U10CA180886 (1), U10CA180888 (1)